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25 (58%) a viral syndrome and 10 (23%) organ dis- 
ease. In group 2, 27 (12%) had a CMV episode, 
6 (22%) viremia, 11 (41%) a viral syndrome, and 
10 (37%) organ disease. Group 3 had no docu- 
mented CMV episodes. The average Length of hospi- 
talization for CMV episodes was 11 days in group I, 
and 2.5 days in group 2. At the end of the study 
51 (74%) patients of group I had a functional graft 
(creatinine clearance >30mLlmin), 8 (12%) had 
severely impaired function (C[ <30 mLlmin), 7 (10%) 
were dead, and 3 (4%) had Lost their graft. The 
corresponding numbers for group 2 were 185 (80%), 
28 (12%), 17 (8%), and for group 3 52 (81%), 4 (6%), 
8 (13%), respectively. OveraLL, 25 transplanted pa- 
tients (6.8%) died during the observation period. 
Conclusions: In our experience, a preemptive 
treatment strategy to address the risk of CMV- 
related morbidity foLLowing renal transplantation 
was associated with a markedly higher incidence of 
CMV episodes in the high-risk group as compared to 
the intermediate-risk group. CMV episodes resulted 
in an average hospitalization Length of 11 days and 
a trend towards an increased toss of graft function 
was noted. Therefore and in the Light of the emer- 
gence of newer oral antivira[ agents with a high 
bioavaiLabiLity such as vaLgancicLovir, the current 
strategy has to be reconsidered. 
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Background: Epstein-Barr virus (EBV) meningoen- 
cephatitis is a rare, normaLLy benign, complication 
of infectious mononucleosis. This disease might 
have a more severe outcome in immunosuppressed 
patients. 
Objective: We describe the case of a heart trans- 
plant recipient who died with presumed EBV 
meningoencephatitis. 
Results: A 68 year-oLd man was admitted, 12 years 
after heart transplantation for a cardiomyopathy 
of unknown origin, for dizziness and fatting without 
vertigo or other neuroLogicaL symptoms. 6 years be- 
fore admission he had presented several episodes 
of acute rejection. His immunosuppressive regi- 
men consisted of cyctosporine 75 mg bid and my- 
cophenotate mofeti[ 1250 mg bid. On admission he 
was afebrite and cLinicaL examination was normaL. 
Three days after admission he presented a somno- 
Lence with fever. Cerebrospina[ fluid (CSF) analysis 
revealed Lymphocytic meningitis with 45 [ympho- 
cytes/mm2 and elevated total protein LeveL. An 
EEG was suggestive for associated encephalitis. MRI 
imaging showed no abnormalities except an old is- 
chemic cerebeLLar Lesion. CSF cultures for bacteria 
(incLuding M. tuberculosis) and fungi were nega- 
tive. CSF analysis by PCR was positive for EBV and 
negative for aLL other herpes viruses (HSV-1, HSV-2, 
VZV, CMV, HHV-6), 3C-virus and ToxopLasmosis. EBV 
PCR was also positive on peripheral blood. Im- 
munosuppression was stopped and therapeutic i.v. 
gangicLovir was administered. During the foLLowing 
2 weeks, partial cLinicaL response, EEG improve- 
ment and decrease of EBV copies, both in LCR and 
peripheral blood, were observed. UnfortunateLy 
the cLinicaL condition rapidly degraded thereafter 
and therapeutical retrieval was decided. He died 
secondarily to a bacterial pneumonia. The autopsy 
confirmed the presence of a T-ceLL meningitis but 
no other infectious agents was documented (in- 
cluding rabies and prion disease). At the time of au- 
topsy, no evidence of inflammatory infiltrates, viral 
RNA (LMP) or proteins (EBR) in brain parenchyma 
could be documented. No malignant process could 
be identified. 
Conclusion: Fatal EBV meningoencephaLitis is a 
very rare entity. Despite extensive search for an 
alternative diagnosis to explain the Lymphocytic 
meningoencephaLitis, we could only document a 
concomitant EBV replication, both in the CSF fluid 
and peripheral blood, in this patient. CLinicians 
should be aware of this possible cause of menin- 
goencephaLitis in immunosuppressed patients. 
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Background: In recent years an increasing number 
of cases with BK virus (BKV) associated nephropa- 
thy after renal transplantation were reported from 
several transplant centers. The diagnosis of BKV 
associated nephropathy requires invasive aLLograft 
biopsy sampling; therefore it is not easy to perform 
for aLL patients. Quantitation of BKV DNA Load in 
plasma or urine has a high positive predictive value 
for BKV associated nephropaty. 
